Generic medicines are medicines that are made to the same standards as brand-name medicines, but are usually much less expensive. They contain the same active ingredients as the brand-name versions, but do not use the same packaging and are not marketed under the same brand name. Generic medicines are an important part of the healthcare system, as they offer cost-effective alternatives to brand-name medicines. They have the same therapeutic effects as brand-name medicines and are just as safe and effective. Generic medicines are regulated in the same way as brand-name medicines. This means that they must meet the same standards of safety, quality, and efficacy as the brand-name products. They must also be tested and approved by the same regulatory authorities before they can be sold. Generic medicines can help reduce healthcare costs for patients and healthcare systems. In many cases, generic medicines are significantly less expensive than their brand-name counterparts, allowing patients to access the treatments they need without breaking the bank. Generic medicines can also help reduce the cost of research and development for new medicines. By using existing medicines as templates, researchers don’t have to start from scratch and can instead focus on developing new treatments. In summary, generic medicines are an important part of the healthcare system. They offer cost-effective alternatives to brand-name medicines, are just as safe and effective, and can help reduce healthcare costs and research and development costs.
Title : Circumventing challenges in developing CVD graphene coating on mild steel: A disruptive approach to remarkable/durable corrosion resistance
Raman Singh, Monash University-Clayton Campus, Australia
Title : Highlighting recent advancements in electromagnetic field subwavelength tailoring using nanoparticle resonant light scattering and related topics
Michael I Tribelsky, Moscow State University, Russian Federation
Title : The impact of nanomedicine: 30,000 orthopedic nano implants with no failures and still counting
Thomas J Webster, Hebei University of Technology, United States
Title : Logistic-modified mathematical model for tumor growth treated with nanosized cargo delivery system
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Current and future of red and black phosphorus nanomaterials
Hai Feng Ji, Drexel University, United States
Title : Azodye photoaligned nanolayers for liquid crystal: New trends
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Title : Atomistic simulation of chemical ordering phenomena in nanostructured intermetallics
Rafal Kozubski, Jagiellonian University in Krakow, Poland
Title : The enhanced cytotoxic effect of curcumin on leukemic stem cells via CD123-targeted nanoparticles
Wariya Nirachonkul, Chiang Mai University, Thailand
Title : Efficiency of nanoparticles (Micromage-B) in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Innovative method of nanotechnology application in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine